Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041897 | SCV000065593 | benign | not specified | 2009-06-24 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000041897 | SCV000169748 | benign | not specified | 2013-10-17 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Athena Diagnostics | RCV000087013 | SCV001146619 | benign | not provided | 2018-09-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000087013 | SCV001719829 | benign | not provided | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003450880 | SCV004181601 | benign | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001274246 | SCV004181602 | benign | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Dept Of Ophthalmology, |
RCV003888404 | SCV004707957 | benign | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Breakthrough Genomics, |
RCV000087013 | SCV005280574 | benign | not provided | criteria provided, single submitter | not provided | ||
NEI Ophthalmic Genomics Laboratory, |
RCV000087013 | SCV000119266 | not provided | not provided | no assertion provided | not provided | ||
Natera, |
RCV001274246 | SCV001458126 | benign | Usher syndrome type 2A | 2020-09-16 | no assertion criteria provided | clinical testing |